Ludwig Enterprises Inc
Ludwig Enterprises, Inc. operates as a genomic technology and health related company in the United States. The company engages in the developing of products that use inflammatory genetic markers to assess the occurrence of inflammation and inflammation related diseases, as well as monitor treatment responses. It also provides Revealia for Life Home Test Kits, that identify the potential to develo… Read more
Ludwig Enterprises Inc (LUDG) - Net Assets
Latest net assets as of September 2025: $-3.31 Million USD
Based on the latest financial reports, Ludwig Enterprises Inc (LUDG) has net assets worth $-3.31 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($261.59K) and total liabilities ($3.57 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-3.31 Million |
| % of Total Assets | -1265.67% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Ludwig Enterprises Inc - Net Assets Trend (2009–2024)
This chart illustrates how Ludwig Enterprises Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ludwig Enterprises Inc (2009–2024)
The table below shows the annual net assets of Ludwig Enterprises Inc from 2009 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-2.38 Million | -62.71% |
| 2023-12-31 | $-1.46 Million | -76.91% |
| 2022-12-31 | $-826.17K | -1331.41% |
| 2021-12-31 | $-57.72K | +52.78% |
| 2020-12-31 | $-122.23K | -38.90% |
| 2019-12-31 | $-88.00K | -77.95% |
| 2018-12-31 | $-49.45K | -27.16% |
| 2017-12-31 | $-38.89K | -369.43% |
| 2015-12-31 | $-8.28K | -165.38% |
| 2014-12-31 | $-3.12K | +97.70% |
| 2013-12-31 | $-135.82K | -4.74% |
| 2012-12-31 | $-129.68K | +57.49% |
| 2011-12-31 | $-305.08K | -3.32% |
| 2010-12-31 | $-295.29K | -8.86% |
| 2009-12-31 | $-271.27K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ludwig Enterprises Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 685227500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $160.51K | % |
| Other Components | $4.72 Million | % |
| Total Equity | $-2.38 Million | 100.00% |
Ludwig Enterprises Inc Competitors by Market Cap
The table below lists competitors of Ludwig Enterprises Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Wira Global Solusi Tbk PT
JK:WGSH
|
$2.85 Million |
|
Enablence Technologies Inc
PINK:ENAFF
|
$2.85 Million |
|
4Front Ventures Corp
OTCQX:FFNTF
|
$2.85 Million |
|
Sanwil Holding SA
WAR:SNW
|
$2.85 Million |
|
Carbine Resources Ltd
AU:CRB
|
$2.84 Million |
|
Atreyu Capital Markets Ltd
TA:ATRY
|
$2.84 Million |
|
Tyranna Resources Ltd
AU:TYX
|
$2.84 Million |
|
KLARSEN EO -20
F:4YA
|
$2.84 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ludwig Enterprises Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -1,461,565 to -2,378,145, a change of -916,580.
- Net loss of 3,016,884 reduced equity.
- Other comprehensive income increased equity by 155,463.
- Other factors increased equity by 1,944,841.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.02 Million | -126.86% |
| Other Comprehensive Income | $155.46K | +6.54% |
| Other Changes | $1.94 Million | +81.78% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Ludwig Enterprises Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | $0.00 | $0.14 | x |
| 2010-12-31 | $0.00 | $0.14 | x |
| 2011-12-31 | $0.00 | $0.14 | x |
| 2012-12-31 | $0.00 | $0.14 | x |
| 2013-12-31 | $0.00 | $0.14 | x |
| 2014-12-31 | $0.00 | $0.14 | x |
| 2015-12-31 | $0.00 | $0.14 | x |
| 2017-12-31 | $0.00 | $0.14 | x |
| 2018-12-31 | $0.00 | $0.14 | x |
| 2019-12-31 | $0.00 | $0.14 | x |
| 2020-12-31 | $0.00 | $0.14 | x |
| 2021-12-31 | $0.00 | $0.14 | x |
| 2022-12-31 | $0.00 | $0.14 | x |
| 2023-12-31 | $-0.01 | $0.14 | x |
| 2024-12-31 | $-0.01 | $0.14 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ludwig Enterprises Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1390269.12%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 0.00% | -253.05% | 0.34x | 0.00x | $-37.40K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-14.49K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-41.79K |
| 2012 | 0.00% | 55.41% | 3.39x | 0.00x | $68.37K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $7.44K |
| 2014 | 0.00% | 98.12% | 22.46x | 0.00x | $133.01K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $133.53K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.37K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.62K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-76.34K |
| 2020 | 0.00% | -43.06% | 0.20x | 0.00x | $-42.01K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-131.70K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-882.53K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.31 Million |
| 2024 | 0.00% | -1390269.12% | 0.00x | 0.00x | $-2.78 Million |
Industry Comparison
This section compares Ludwig Enterprises Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ludwig Enterprises Inc (LUDG) | $-3.31 Million | 0.00% | N/A | $2.85 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |